Biotechnology
The Biotechnology industry has a total of 585 stocks, with a combined market cap of $1.31 trillion and total revenue of $116.08 billion.
Market Cap
1.31T
Revenue
116.08B
Profits
-38.04B
PE Ratio
n/a
Profit Margin
-32.77%
Dividend Yield
0.04%
585 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 130.87B | 0.60% | 899,706 | 12.59B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 78.83B | 1.92% | 702,761 | 15.53B |
| 3 | MRNA | Moderna, Inc. | 63.11B | 8.55% | 19,243,615 | 2.23B |
| 4 | ARGX | argenx SE | 62.32B | 1.13% | 245,901 | 5.32B |
| 5 | RVMD | Revolution Medicines, Inc. | 42.21B | 0.52% | 1,821,066 | - |
| 6 | ONC | BeOne Medicines AG | 40.19B | 1.55% | 285,994 | 6.13B |
| 7 | RPRX | Royalty Pharma plc | 33.88B | 0.79% | 2,062,507 | 2.54B |
| 8 | ALNY | Alnylam Pharmaceuticals, Inc. | 32.85B | 2.57% | 968,924 | 4.80B |
| 9 | ROIV | Roivant Sciences Ltd. | 28.88B | 1.04% | 7,603,968 | 7.53M |
| 10 | INSM | Insmed Incorporated | 27.07B | 1.14% | 1,592,256 | 1.14B |
| 11 | INCY | Incyte Corporation | 25.87B | 2.30% | 1,452,797 | 5.82B |
| 12 | BNTX | BioNTech SE | 24.78B | 2.95% | 707,961 | 3.03B |
| 13 | GMAB | Genmab A/S | 20.59B | 0.39% | 2,703,019 | 4.13B |
| 14 | JAZZ | Jazz Pharmaceuticals plc | 15.83B | 0.10% | 569,585 | 4.60B |
| 15 | ASND | Ascendis Pharma A/S | 15.70B | -3.49% | 1,060,373 | 1.20B |
| 16 | EXEL | Exelixis, Inc. | 14.49B | 3.01% | 1,687,967 | 2.44B |
| 17 | SMMT | Summit Therapeutics Inc. | 14.14B | 2.43% | 6,134,930 | - |
| 18 | BBIO | BridgeBio Pharma, Inc. | 13.16B | -1.45% | 2,334,288 | 713.07M |
| 19 | BMRN | BioMarin Pharmaceutical Inc. | 12.60B | 0.54% | 1,380,832 | 3.41B |
| 20 | HALO | Halozyme Therapeutics, Inc. | 12.45B | 1.14% | 1,967,574 | 1.66B |
| 21 | CORT | Corcept Therapeutics Incorporated | 12.42B | 2.73% | 861,601 | 830.81M |
| 22 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.35B | 1.00% | 153,300 | 1.28B |
| 23 | TECH | Bio-Techne Corporation | 11.36B | 0.11% | 3,762,201 | 1.22B |
| 24 | AXSM | Axsome Therapeutics, Inc. | 11.22B | 1.09% | 681,362 | 776.57M |
| 25 | KRYS | Krystal Biotech, Inc. | 10.03B | 0.62% | 280,926 | 440.48M |
| 26 | KYMR | Kymera Therapeutics, Inc. | 9.85B | 1.85% | 570,486 | 105.00M |
| 27 | TWST | Twist Bioscience Corporation | 9.75B | 8.73% | 3,370,681 | 431.80M |
| 28 | CYTK | Cytokinetics, Incorporated | 9.72B | 0.76% | 1,398,170 | 67.67M |
| 29 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.57B | 2.96% | 3,181,843 | 669.50M |
| 30 | ABVX | ABIVAX Société Anonyme | 9.38B | 4.66% | 1,151,903 | 5.67M |
| 31 | PTGX | Protagonist Therapeutics, Inc. | 9.30B | 0.60% | 558,898 | 281.99M |
| 32 | PCVX | Vaxcyte, Inc. | 8.98B | 2.72% | 1,309,150 | - |
| 33 | IBRX | ImmunityBio, Inc. | 8.97B | 6.95% | 19,159,326 | 165.79M |
| 34 | CAI | Caris Life Sciences, Inc. | 8.74B | 9.61% | 7,661,747 | 989.61M |
| 35 | PRAX | Praxis Precision Medicines, Inc. | 8.67B | 0.48% | 555,919 | 7.46M |
| 36 | SYRE | Spyre Therapeutics, Inc. | 8.17B | 1.66% | 1,438,884 | - |
| 37 | TGTX | TG Therapeutics, Inc. | 8.01B | 1.11% | 1,467,854 | 799.54M |
| 38 | IMVT | Immunovant, Inc. | 7.78B | 3.49% | 1,330,615 | - |
| 39 | IONS | Ionis Pharmaceuticals, Inc. | 7.77B | 4.26% | 4,079,568 | 874.09M |
| 40 | BLTE | Belite Bio, Inc | 6.86B | 0.67% | 136,024 | - |
| 41 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.82B | 1.03% | 617,730 | 239.92M |
| 42 | CGON | CG Oncology, Inc. | 6.70B | 2.02% | 894,291 | 6.23M |
| 43 | ORKA | Oruka Therapeutics, Inc. | 6.47B | 4.47% | 1,046,949 | - |
| 44 | MIRM | Mirum Pharmaceuticals, Inc. | 6.42B | 1.49% | 926,224 | 618.07M |
| 45 | TVTX | Travere Therapeutics, Inc. | 6.10B | 1.98% | 1,384,695 | 591.33M |
| 46 | SRRK | Scholar Rock Holding Corporation | 5.97B | -0.71% | 3,485,702 | - |
| 47 | COGT | Cogent Biosciences, Inc. | 5.76B | 2.00% | 1,189,526 | - |
| 48 | LGND | Ligand Pharmaceuticals Incorporated | 5.68B | 3.45% | 248,805 | 290.54M |
| 49 | PTCT | PTC Therapeutics, Inc. | 5.68B | 0.61% | 1,090,412 | 1.01B |
| 50 | DNTH | Dianthus Therapeutics, Inc. | 5.66B | -1.34% | 1,140,557 | 1.90M |
| 51 | XENE | Xenon Pharmaceuticals Inc. | 5.55B | 1.04% | 1,832,045 | 7.50M |
| 52 | CRSP | CRISPR Therapeutics AG | 5.54B | 9.80% | 3,000,241 | 13.39M |
| 53 | ERAS | Erasca, Inc. | 5.37B | -0.13% | 7,548,639 | - |
| 54 | DFTX | Definium Therapeutics, Inc. | 5.20B | 2.19% | 1,729,891 | - |
| 55 | EWTX | Edgewise Therapeutics, Inc. | 5.10B | 3.30% | 2,407,771 | - |
| 56 | PBLS | Parabilis Medicines, Inc. | 5.05B | 10.85% | 1,093,176 | 148.00K |
| 57 | ACAD | ACADIA Pharmaceuticals Inc. | 4.73B | -0.33% | 1,276,741 | 1.14B |
| 58 | MANE | Veradermics, Incorporated | 4.54B | 6.11% | 766,415 | - |
| 59 | IOVA | Iovance Biotherapeutics, Inc. | 4.54B | 1.52% | 24,203,890 | 324.97M |
| 60 | TLX | Telix Pharmaceuticals Limited | 4.22B | 5.71% | 412,912 | 890.79M |
| 61 | RLAY | Relay Therapeutics, Inc. | 4.21B | 1.86% | 3,095,724 | 10.35M |
| 62 | CELC | Celcuity Inc. | 4.15B | 2.82% | 692,108 | - |
| 63 | ABCL | AbCellera Biologics Inc. | 4.13B | 9.08% | 8,045,088 | 66.17M |
| 64 | TNGX | Tango Therapeutics, Inc. | 3.96B | 0.60% | 1,721,938 | 53.81M |
| 65 | IDYA | IDEAYA Biosciences, Inc. | 3.73B | 2.33% | 757,752 | 234.13M |
| 66 | ELVN | Enliven Therapeutics, Inc. | 3.68B | 2.28% | 1,963,459 | - |
| 67 | TARS | Tarsus Pharmaceuticals, Inc. | 3.47B | 1.79% | 474,857 | 606.33M |
| 68 | VKTX | Viking Therapeutics, Inc. | 3.42B | -0.54% | 2,086,630 | - |
| 69 | LEGN | Legend Biotech Corporation | 3.41B | 3.41% | 1,953,608 | 1.27B |
| 70 | DYN | Dyne Therapeutics, Inc. | 3.37B | 4.33% | 2,846,760 | - |
| 71 | ARQT | Arcutis Biotherapeutics, Inc. | 3.33B | 1.22% | 5,862,457 | 463.98M |
| 72 | RCUS | Arcus Biosciences, Inc. | 3.25B | 3.61% | 2,010,957 | 117.00M |
| 73 | DNLI | Denali Therapeutics Inc. | 3.22B | 0.35% | 1,421,472 | 3.60M |
| 74 | MBX | MBX Biosciences, Inc. | 3.08B | 3.77% | 969,810 | - |
| 75 | CLDX | Celldex Therapeutics, Inc. | 3.06B | 0.70% | 1,278,872 | 158.00K |
| 76 | QURE | uniQure N.V. | 3.06B | 3.77% | 798,694 | 18.67M |
| 77 | ZLAB | Zai Lab Limited | 2.90B | 4.62% | 673,109 | 449.61M |
| 78 | PGEN | Precigen, Inc. | 2.82B | 5.78% | 9,364,227 | 85.72M |
| 79 | IMNM | Immunome, Inc. | 2.72B | 2.00% | 890,742 | 4.02M |
| 80 | PHVS | Pharvaris N.V. | 2.67B | 1.20% | 1,137,444 | - |
| 81 | IRON | Disc Medicine, Inc. | 2.66B | 0.89% | 621,690 | - |
| 82 | NRIX | Nurix Therapeutics, Inc. | 2.65B | 1.39% | 1,511,894 | 36.77M |
| 83 | NAMS | NewAmsterdam Pharma Company N.V. | 2.62B | 3.54% | 2,310,526 | 7.12M |
| 84 | GPCR | Structure Therapeutics Inc. | 2.50B | -1.13% | 1,011,424 | - |
| 85 | HRMY | Harmony Biosciences Holdings, Inc. | 2.49B | 1.26% | 641,414 | 959.90M |
| 86 | VRDN | Viridian Therapeutics, Inc. | 2.48B | -2.32% | 1,268,415 | 71.13M |
| 87 | MLYS | Mineralys Therapeutics, Inc. | 2.47B | 1.60% | 1,141,567 | - |
| 88 | VERA | Vera Therapeutics, Inc. | 2.47B | 7.87% | 3,885,468 | - |
| 89 | BEAM | Beam Therapeutics Inc. | 2.47B | 6.80% | 2,429,235 | 156.04M |
| 90 | NKTR | Nektar Therapeutics | 2.33B | 1.45% | 1,264,862 | 54.59M |
| 91 | SLS | SELLAS Life Sciences Group, Inc. | 2.33B | -1.11% | 4,811,865 | - |
| 92 | AUPH | Aurinia Pharmaceuticals Inc. | 2.26B | - | 850,171 | 311.51M |
| 93 | OCUL | Ocular Therapeutix, Inc. | 2.23B | 2.74% | 2,311,371 | 52.06M |
| 94 | PVLA | Palvella Therapeutics, Inc. | 2.22B | 1.91% | 157,921 | - |
| 95 | GENB | Generate Biomedicines, Inc. | 2.20B | 9.18% | 2,205,740 | 26.48M |
| 96 | SRPT | Sarepta Therapeutics, Inc. | 2.18B | 4.61% | 2,588,120 | 1.97B |
| 97 | TRVI | Trevi Therapeutics, Inc. | 2.17B | 1.33% | 1,500,736 | - |
| 98 | URGN | UroGen Pharma Ltd. | 2.15B | 1.06% | 699,362 | 188.73M |
| 99 | NUVB | Nuvation Bio Inc. | 2.13B | 5.02% | 5,738,782 | 169.90M |
| 100 | BHVN | Biohaven Ltd. | 2.10B | 15.56% | 5,833,554 | - |
| 101 | ZBIO | Zenas BioPharma, Inc. | 2.08B | -1.08% | 527,840 | 1.00M |
| 102 | KOD | Kodiak Sciences Inc. | 2.06B | 0.24% | 826,147 | - |
| 103 | VCEL | Vericel Corporation | 2.05B | -0.45% | 536,418 | 306.30M |
| 104 | RAPP | Rapport Therapeutics, Inc. | 2.01B | 1.35% | 397,297 | 20.00M |
| 105 | AGIO | Agios Pharmaceuticals, Inc. | 2.01B | 2.00% | 868,567 | 98.34M |
| 106 | ADMA | ADMA Biologics, Inc. | 2.00B | 0.56% | 2,131,483 | 512.28M |
| 107 | GHRS | GH Research PLC | 1.97B | 3.50% | 501,549 | - |
| 108 | ZYME | Zymeworks Inc. | 1.95B | 4.73% | 1,330,336 | 37.13M |
| 109 | FTRE | Fortrea Holdings Inc. | 1.93B | 1.55% | 2,286,808 | 2.68B |
| 110 | COAG | Hemab Therapeutics Holdings, Inc. | 1.92B | 0.54% | 429,041 | - |
| 111 | MESO | Mesoblast Limited | 1.90B | 3.19% | 143,527 | 120.25M |
| 112 | RXRX | Recursion Pharmaceuticals, Inc. | 1.90B | 10.97% | 28,251,171 | 54.86M |
| 113 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.89B | 6.29% | 3,447,946 | 208.78M |
| 114 | STOK | Stoke Therapeutics, Inc. | 1.87B | 3.65% | 960,034 | 27.59M |
| 115 | LKFT | Lakefront Biotherapeutics NV | 1.86B | 5.01% | 467,611 | 1.13B |
| 116 | VIR | Vir Biotechnology, Inc. | 1.85B | 3.80% | 1,794,364 | 303.23M |
| 117 | SEPN | Septerna, Inc. | 1.84B | 2.76% | 241,527 | 98.88M |
| 118 | XNCR | Xencor, Inc. | 1.83B | 3.71% | 1,026,901 | 104.97M |
| 119 | NBTX | Nanobiotix S.A. | 1.78B | 4.30% | 99,770 | 38.27M |
| 120 | BRVE | Braveheart Bio, Inc. | 1.78B | 0.95% | 577,364 | - |
| 121 | NTLA | Intellia Therapeutics, Inc. | 1.72B | 6.70% | 5,760,971 | 59.51M |
| 122 | TSHA | Taysha Gene Therapies, Inc. | 1.68B | 1.78% | 4,082,270 | 5.49M |
| 123 | TYRA | Tyra Biosciences, Inc. | 1.68B | 0.33% | 511,724 | - |
| 124 | KLRA | Kailera Therapeutics, Inc. | 1.67B | 1.73% | 1,036,226 | - |
| 125 | IMCR | Immunocore Holdings plc | 1.66B | 2.25% | 259,262 | 430.78M |
| 126 | NVAX | Novavax, Inc. | 1.65B | 6.95% | 8,876,132 | 413.80M |
| 127 | ANAB | AnaptysBio, Inc. | 1.63B | 1.38% | 439,570 | 232.39M |
| 128 | ABSI | Absci Corporation | 1.59B | 15.30% | 8,665,817 | 1.56M |
| 129 | LTGO | Latigo Biotherapeutics, Inc. | 1.59B | 3.77% | 430,919 | - |
| 130 | SNDX | Syndax Pharmaceuticals, Inc. | 1.58B | 2.31% | 2,520,840 | 252.25M |
| 131 | KARD | Kardigan, Inc. | 1.56B | -3.58% | 710,229 | - |
| 132 | INBX | Inhibrx Biosciences, Inc. | 1.54B | 2.91% | 217,279 | 1.30M |
| 133 | INVA | Innoviva, Inc. | 1.52B | -0.71% | 1,188,091 | 440.00M |
| 134 | BCAX | Bicara Therapeutics Inc. | 1.49B | 2.68% | 491,967 | - |
| 135 | AVLN | Avalyn Pharma Inc. | 1.48B | -3.69% | 317,013 | - |
| 136 | DRTS | Alpha Tau Medical Ltd. | 1.43B | 2.99% | 858,879 | - |
| 137 | RARE | Ultragenyx Pharmaceutical Inc. | 1.43B | 12.58% | 12,427,775 | 717.00M |
| 138 | DMRA | Damora Therapeutics, Inc. | 1.41B | -7.13% | 605,292 | - |
| 139 | AAPG | Ascentage Pharma Group International | 1.40B | -0.19% | 3,163 | 94.61M |
| 140 | TRAX | First Tracks Biotherapeutics, Inc. | 1.40B | 0.51% | 554,757 | - |
| 141 | AVBP | ArriVent BioPharma, Inc. | 1.40B | 2.60% | 456,427 | - |
| 142 | SVRA | Savara Inc. | 1.38B | 5.65% | 1,228,638 | - |
| 143 | CGEM | Cullinan Therapeutics, Inc. | 1.37B | 3.54% | 756,666 | - |
| 144 | LBRX | LB Pharmaceuticals Inc | 1.36B | -1.01% | 314,496 | - |
| 145 | OMER | Omeros Corporation | 1.34B | 6.40% | 2,496,460 | 38.42M |
| 146 | ORIC | ORIC Pharmaceuticals, Inc. | 1.34B | 2.71% | 1,156,335 | - |
| 147 | MAZE | Maze Therapeutics, Inc. | 1.30B | -2.01% | 363,522 | 20.00M |
| 148 | VOR | Vor Biopharma Inc. | 1.30B | -0.27% | 1,543,929 | - |
| 149 | AKTS | Aktis Oncology, Inc. | 1.27B | 0.66% | 500,877 | 10.06M |
| 150 | MGTX | MeiraGTx Holdings plc | 1.25B | 2.27% | 953,000 | 397.50M |
| 151 | ANRO | Alto Neuroscience, Inc. | 1.22B | 3.27% | 410,960 | - |
| 152 | REPL | Replimune Group, Inc. | 1.21B | -0.69% | 1,295,159 | - |
| 153 | IMTX | Immatics N.V. | 1.21B | 2.08% | 415,889 | 47.65M |
| 154 | APMD | Apnimed, Inc. | 1.17B | 3.77% | 355,719 | 115.12M |
| 155 | SPTX | Seaport Therapeutics, Inc. | 1.17B | -1.45% | 205,613 | - |
| 156 | MNKD | MannKind Corporation | 1.15B | 0.85% | 2,733,344 | 393.63M |
| 157 | ODTX | Odyssey Therapeutics, Inc. | 1.11B | 0.43% | 524,247 | 99.00K |
| 158 | JBIO | Jade Biosciences, Inc. | 1.09B | 2.94% | 815,835 | - |
| 159 | OBX | Obsidian Therapeutics, Inc. | 1.08B | 2.04% | 829,640 | - |
| 160 | GLUE | Monte Rosa Therapeutics, Inc. | 1.07B | -0.40% | 1,294,110 | 28.73M |
| 161 | SLBT | SL Science Holding Limited | 1.07B | 3.31% | 44,529 | 3.27M |
| 162 | CRVS | Corvus Pharmaceuticals, Inc. | 1.06B | 2.62% | 1,534,754 | - |
| 163 | MLTX | MoonLake Immunotherapeutics | 1.05B | -0.88% | 2,298,118 | - |
| 164 | KURA | Kura Oncology, Inc. | 1.04B | 4.64% | 1,852,024 | 77.23M |
| 165 | ATTO | Attovia Therapeutics, Inc. | 1.04B | 2.16% | 292,606 | 1.80M |
| 166 | JANX | Janux Therapeutics, Inc. | 1.03B | 3.75% | 809,961 | 24.00M |
| 167 | HELP | Cybin Inc. | 1.02B | 4.08% | 3,344,325 | - |
| 168 | ALMS | Alumis Inc. | 1.01B | -1.51% | 3,515,368 | 7.40M |
| 169 | ABUS | Arbutus Biopharma Corporation | 1.00B | 0.40% | 2,714,961 | 181.72M |
| 170 | ANL | Adlai Nortye Group Ltd. | 984.00M | -1.55% | 91,495 | 18.06M |
| 171 | SGP | SpyGlass Pharma, Inc. | 981.03M | 2.55% | 235,587 | - |
| 172 | SLDB | Solid Biosciences Inc. | 951.09M | 1.72% | 1,193,300 | - |
| 173 | SANA | Sana Biotechnology, Inc. | 928.02M | 6.16% | 2,916,202 | - |
| 174 | IMMX | Immix Biopharma, Inc. | 909.98M | 6.71% | 1,185,668 | - |
| 175 | FTH | Faeth Therapeutics, Inc. | 907.77M | 2.60% | 362,978 | - |
| 176 | LXRX | Lexicon Pharmaceuticals, Inc. | 905.49M | 0.74% | 2,235,725 | 41.47M |
| 177 | IVA | Inventiva S.A. | 899.28M | -1.06% | 1,811,255 | 7.94M |
| 178 | AVTX | Avalo Therapeutics, Inc. | 895.08M | 0.66% | 691,245 | 59.00K |
| 179 | TBPH | Theravance Biopharma, Inc. | 884.70M | 0.06% | 306,932 | 104.31M |
| 180 | WVE | Wave Life Sciences, Inc. | 874.89M | -1.44% | 2,171,817 | 65.37M |
| 181 | CADL | Candel Therapeutics, Inc. | 867.72M | 2.90% | 798,545 | - |
| 182 | OLMA | Olema Pharmaceuticals, Inc. | 866.23M | 1.75% | 927,406 | - |
| 183 | RIGL | Rigel Pharmaceuticals, Inc. | 856.47M | 3.08% | 165,707 | 276.79M |
| 184 | GERN | Geron Corporation | 848.06M | 2.33% | 9,819,461 | 204.56M |
| 185 | ARDX | Ardelyx, Inc. | 842.25M | -0.29% | 4,231,974 | 450.89M |
| 186 | BLSM | BlossomHill Therapeutics, Inc. | 821.86M | 2.17% | 247,626 | - |
| 187 | ACHV | Achieve Life Sciences, Inc. | 813.96M | 6.60% | 1,871,053 | - |
| 188 | FDMT | 4D Molecular Therapeutics, Inc. | 810.99M | 6.69% | 930,541 | 92.01M |
| 189 | CLYM | Climb Bio, Inc. | 807.55M | -0.35% | 987,372 | - |
| 190 | DSGN | Design Therapeutics, Inc. | 801.67M | 2.40% | 601,179 | - |
| 191 | ACRS | Aclaris Therapeutics, Inc. | 794.87M | 1.50% | 3,822,970 | 8.22M |
| 192 | ANNX | Annexon, Inc. | 790.54M | 6.11% | 3,119,706 | - |
| 193 | SLN | Silence Therapeutics plc | 764.66M | 1.60% | 690,466 | 615.00K |
| 194 | PHAR | Pharming Group N.V. | 762.39M | 1.70% | 5,400 | 366.48M |
| 195 | GYRE | Gyre Therapeutics, Inc. | 761.32M | 7.16% | 143,908 | 109.82M |
| 196 | DBVT | DBV Technologies S.A. | 754.91M | 6.53% | 158,768 | 5.04M |
| 197 | CBIO | Crescent Biopharma, Inc. | 717.77M | -2.39% | 665,895 | 11.88M |
| 198 | ZVRA | Zevra Therapeutics, Inc. | 703.10M | 0.34% | 1,591,440 | 136.07M |
| 199 | NVCT | Nuvectis Pharma, Inc. | 696.59M | -2.24% | 240,802 | - |
| 200 | SGMT | Sagimet Biosciences Inc. | 694.31M | 6.79% | 1,019,048 | - |
| 201 | MNPR | Monopar Therapeutics Inc. | 689.34M | 1.23% | 206,598 | - |
| 202 | VSTM | Verastem, Inc. | 683.75M | 3.14% | 1,734,244 | 87.53M |
| 203 | MDXG | MiMedx Group, Inc. | 683.62M | -0.85% | 935,337 | 355.17M |
| 204 | AURA | Aura Biosciences, Inc. | 683.41M | -2.08% | 916,367 | - |
| 205 | NGNE | Neurogene Inc. | 648.57M | -6.52% | 171,523 | 925.00K |
| 206 | OABI | OmniAb, Inc. | 645.53M | 2.07% | 983,968 | 38.46M |
| 207 | ALT | Altimmune, Inc. | 630.24M | - | 3,457,393 | 31.00K |
| 208 | MPLT | MapLight Therapeutics, Inc. | 629.12M | -0.70% | 545,817 | - |
| 209 | VALN | Valneva SE | 621.20M | 0.15% | 11,003 | 163.30M |
| 210 | OCS | Oculis Holding AG | 616.09M | 0.81% | 248,044 | 1.45M |
| 211 | PHAT | Phathom Pharmaceuticals, Inc. | 615.58M | 0.78% | 1,364,063 | 239.66M |
| 212 | CTMX | CytomX Therapeutics, Inc. | 614.48M | 1.99% | 4,214,978 | 18.30M |
| 213 | SCTX | Scribe Therapeutics Inc. | 608.46M | 10.45% | 303,841 | 33.30M |
| 214 | CRMD | CorMedix Inc. | 607.19M | -0.38% | 684,558 | 462.25M |
| 215 | DRUG | Bright Minds Biosciences Inc. | 602.76M | 4.13% | 67,351 | - |
| 216 | ALLO | Allogene Therapeutics, Inc. | 597.70M | 2.37% | 3,947,983 | 4.64M |
| 217 | AGMB | AgomAb Therapeutics NV | 594.92M | 5.87% | 339,332 | - |
| 218 | STTK | Shattuck Labs, Inc. | 587.13M | -0.51% | 654,282 | 1.00M |
| 219 | PRME | Prime Medicine, Inc. | 558.62M | 4.67% | 3,253,715 | 4.07M |
| 220 | EPRX | Eupraxia Pharmaceuticals Inc. | 551.11M | 3.58% | 257,765 | - |
| 221 | CAPR | Capricor Therapeutics, Inc. | 547.67M | 10.05% | 3,938,770 | 11.13M |
| 222 | PROK | ProKidney Corp. | 544.18M | -2.70% | 1,048,838 | 818.00K |
| 223 | ARVN | Arvinas, Inc. | 543.36M | 1.84% | 533,103 | 316.70M |
| 224 | RGNX | REGENXBIO Inc. | 542.30M | 2.94% | 1,692,174 | 174.48M |
| 225 | TECX | Tectonic Therapeutic, Inc. | 531.94M | -2.51% | 186,778 | - |
| 226 | DNA | Ginkgo Bioworks Holdings, Inc. | 527.95M | 11.05% | 2,660,017 | 132.42M |
| 227 | OVID | Ovid Therapeutics Inc. | 527.30M | 0.75% | 1,985,776 | 1.58M |
| 228 | ENTX | Entera Bio Ltd. | 524.62M | 2.36% | 310,172 | 42.00K |
| 229 | INDP | Indaptus Therapeutics, Inc. | 523.64M | 22.43% | 920,856 | - |
| 230 | ASMB | Assembly Biosciences, Inc. | 515.94M | -0.55% | 364,770 | 74.85M |
| 231 | AUTL | Autolus Therapeutics plc | 511.03M | 2.67% | 1,091,190 | 117.39M |
| 232 | CTNM | Contineum Therapeutics, Inc. | 496.98M | -4.00% | 580,101 | - |
| 233 | PBYI | Puma Biotechnology, Inc. | 491.42M | 1.38% | 206,101 | 231.24M |
| 234 | ARCT | Arcturus Therapeutics Holdings Inc. | 481.20M | 8.53% | 1,302,455 | 29.37M |
| 235 | VOGX | Vogenx, Inc. | 475.01M | 2.22% | 209,757 | - |
| 236 | PRLD | Prelude Therapeutics Incorporated | 470.69M | 2.24% | 533,876 | 22.42M |
| 237 | EIKN | Eikon Therapeutics, Inc. | 465.82M | 1.06% | 640,256 | - |
| 238 | RLMD | Relmada Therapeutics, Inc. | 448.01M | -0.47% | 772,868 | - |
| 239 | IRD | Opus Genetics, Inc. | 439.27M | -2.40% | 1,531,534 | 9.86M |
| 240 | ZURA | Zura Bio Limited | 437.94M | -0.87% | 1,668,360 | - |
| 241 | CABA | Cabaletta Bio, Inc. | 437.43M | 3.61% | 4,258,044 | - |
| 242 | KYTX | Kyverna Therapeutics, Inc. | 435.38M | 2.03% | 530,753 | - |
| 243 | PRTA | Prothena Corporation plc | 434.31M | 2.67% | 404,758 | 54.53M |
| 244 | AVIR | Atea Pharmaceuticals, Inc. | 421.88M | 2.14% | 279,428 | - |
| 245 | CCCC | C4 Therapeutics, Inc. | 420.13M | -1.01% | 1,758,173 | 35.04M |
| 246 | IKT | Inhibikase Therapeutics, Inc. | 418.77M | -0.43% | 475,530 | 1.00 |
| 247 | EDIT | Editas Medicine, Inc. | 417.74M | 0.37% | 3,515,907 | 47.01M |
| 248 | SPRY | ARS Pharmaceuticals, Inc. | 412.71M | -0.36% | 1,873,172 | 116.93M |
| 249 | RZLT | Rezolute, Inc. | 412.64M | -0.75% | 1,836,942 | - |
| 250 | ARTV | Artiva Biotherapeutics, Inc. | 412.63M | -1.86% | 456,479 | 251.00K |
| 251 | TTRX | Turn Therapeutics Inc. | 411.67M | 0.73% | 199,847 | - |
| 252 | LRMR | Larimar Therapeutics, Inc. | 396.66M | -3.31% | 1,196,102 | - |
| 253 | BNTC | Benitec Biopharma Inc. | 396.27M | 2.90% | 91,249 | - |
| 254 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 392.05M | 2.73% | 417,374 | - |
| 255 | VTVT | vTv Therapeutics Inc. | 390.14M | 3.09% | 33,385 | 36.84M |
| 256 | RCKT | Rocket Pharmaceuticals, Inc. | 384.21M | 0.57% | 1,858,762 | - |
| 257 | FENC | Fennec Pharmaceuticals Inc. | 378.02M | 2.18% | 128,549 | 59.22M |
| 258 | GALT | Galectin Therapeutics Inc. | 374.15M | 0.82% | 171,126 | - |
| 259 | DMAC | DiaMedica Therapeutics Inc. | 369.39M | 3.32% | 257,763 | - |
| 260 | ENTA | Enanta Pharmaceuticals, Inc. | 364.65M | -1.42% | 277,679 | 65.26M |
| 261 | OCGN | Ocugen, Inc. | 349.28M | 3.17% | 3,914,512 | 4.58M |
| 262 | OBIO | Orchestra BioMed Holdings, Inc. | 347.41M | -3.83% | 411,201 | 31.98M |
| 263 | XFOR | X4 Pharmaceuticals, Inc. | 347.01M | -0.28% | 635,024 | 15.85M |
| 264 | EYPT | EyePoint, Inc. | 343.99M | 15.65% | 6,975,498 | 2.79M |
| 265 | LXEO | Lexeo Therapeutics, Inc. | 342.94M | 0.48% | 1,099,053 | - |
| 266 | IPSC | Century Therapeutics, Inc. | 340.42M | 1.08% | 430,182 | 109.16M |
| 267 | EVMN | Evommune, Inc. | 340.06M | - | 405,793 | 10.00M |
| 268 | CMPX | Compass Therapeutics, Inc. | 333.16M | 1.09% | 2,515,917 | 850.00K |
| 269 | AGEN | Agenus Inc. | 325.05M | 0.14% | 765,344 | 132.69M |
| 270 | SION | Sionna Therapeutics, Inc. | 324.63M | 1.99% | 1,477,236 | - |
| 271 | QTTB | Q32 Bio Inc. | 323.30M | -1.09% | 383,458 | 53.74M |
| 272 | ABEO | Abeona Therapeutics Inc. | 319.66M | 4.10% | 3,463,114 | 25.52M |
| 273 | SABS | SAB Biotherapeutics, Inc. | 318.45M | 3.24% | 374,463 | 114.70K |
| 274 | VNDA | Vanda Pharmaceuticals Inc. | 308.96M | 2.20% | 646,808 | 215.72M |
| 275 | IFRX | InflaRx N.V. | 303.58M | 0.98% | 657,782 | -11.54K |
| 276 | FATE | Fate Therapeutics, Inc. | 301.95M | 3.28% | 5,137,106 | 6.49M |
| 277 | PALI | Palisade Bio, Inc. | 296.26M | 0.59% | 5,398,114 | 500.00K |
| 278 | VCRE | Vicore Pharma Holding AB (publ) | 295.90M | -2.35% | 16,221 | 412.09K |
| 279 | CUVL | Clinuvel Pharmaceuticals Limited | 292.65M | 0.34% | 4,376 | 65.05M |
| 280 | ZNTL | Zentalis Pharmaceuticals, Inc. | 291.59M | -0.65% | 1,090,672 | 26.87M |
| 281 | UPB | Upstream Bio, Inc. | 290.83M | -0.38% | 533,870 | 3.16M |
| 282 | IMRX | Immuneering Corporation | 288.55M | 0.22% | 576,434 | - |
| 283 | FULC | Fulcrum Therapeutics, Inc. | 287.64M | -0.53% | 888,083 | 80.00M |
| 284 | YARW | Yarrow Bioscience, Inc. | 284.53M | 17.89% | 187,714 | - |
| 285 | PYXS | Pyxis Oncology, Inc. | 284.42M | 2.10% | 476,548 | 11.04M |
| 286 | CUE | Cue Biopharma, Inc. | 274.89M | 10.74% | 195,071 | 37.66M |
| 287 | GLSI | Greenwich LifeSciences, Inc. | 269.93M | 17.66% | 246,744 | - |
| 288 | PRQR | ProQR Therapeutics N.V. | 266.72M | 1.61% | 430,943 | 21.05M |
| 289 | ACIU | AC Immune SA | 266.46M | 1.13% | 93,345 | 21.67M |
| 290 | LYEL | Lyell Immunopharma, Inc. | 264.66M | 0.19% | 132,996 | 27.00K |
| 291 | MGNX | MacroGenics, Inc. | 263.08M | 1.23% | 438,002 | 175.14M |
| 292 | LCTX | Lineage Cell Therapeutics, Inc. | 260.49M | -3.74% | 901,699 | 13.08M |
| 293 | BCYC | Bicycle Therapeutics plc | 257.57M | 1.24% | 185,114 | 61.21M |
| 294 | STRO | Sutro Biopharma, Inc. | 256.68M | -0.77% | 348,383 | 45.70M |
| 295 | CAMP | Camp4 Therapeutics Corporation | 252.90M | 4.40% | 93,439 | 4.22M |
| 296 | FHTX | Foghorn Therapeutics Inc. | 249.42M | 0.72% | 246,006 | 36.74M |
| 297 | TRDA | Entrada Therapeutics, Inc. | 248.79M | 0.15% | 297,313 | 4.69M |
| 298 | NGEN | NervGen Pharma Corp. | 244.08M | 6.57% | 1,159,392 | - |
| 299 | ALXO | ALX Oncology Holdings Inc. | 240.60M | -1.14% | 526,475 | - |
| 300 | RNAC | Cartesian Therapeutics, Inc. | 237.81M | -0.63% | 164,419 | 1.48M |
| 301 | CGEN | Compugen Ltd. | 233.02M | 2.07% | 122,757 | 74.00M |
| 302 | WHWK | Whitehawk Therapeutics, Inc. | 232.60M | 0.99% | 130,071 | 7.15M |
| 303 | YDES | YD Bio Limited | 227.84M | -12.43% | 544,965 | 1.24M |
| 304 | ADAG | Adagene Inc. | 226.27M | 6.31% | 261,067 | 9.29M |
| 305 | KROS | Keros Therapeutics, Inc. | 225.24M | 5.77% | 274,087 | 15.01M |
| 306 | AVXL | Anavex Life Sciences Corp. | 223.40M | 2.12% | 364,499 | - |
| 307 | IVVD | Invivyd, Inc. | 219.95M | -7.34% | 5,842,966 | 58.37M |
| 308 | TARA | Protara Therapeutics, Inc. | 218.65M | 2.21% | 654,148 | - |
| 309 | PLX | Protalix BioTherapeutics, Inc. | 217.54M | 0.75% | 321,890 | 80.62M |
| 310 | ELDN | Eledon Pharmaceuticals, Inc. | 215.55M | -0.75% | 558,375 | - |
| 311 | SLGL | Sol-Gel Technologies Ltd. | 210.57M | 1.38% | 45,141 | 1.80M |
| 312 | VRXA | Veraxa Biotech AG | 207.87M | -2.65% | 47,985 | 29.54K |
| 313 | ALEC | Alector, Inc. | 206.57M | -3.90% | 931,233 | 13.86M |
| 314 | PEPG | PepGen Inc. | 205.70M | 2.41% | 447,626 | - |
| 315 | NKTX | Nkarta, Inc. | 201.27M | -2.09% | 531,366 | - |
| 316 | MSLE | Satellos Bioscience Inc. | 201.22M | 4.09% | 17,615 | - |
| 317 | SRZN | Surrozen, Inc. | 199.69M | 0.35% | 268,456 | 11.51M |
| 318 | TNXP | Tonix Pharmaceuticals Holding Corp. | 195.86M | -2.89% | 388,745 | 29.10M |
| 319 | ORMP | Oramed Pharmaceuticals Inc. | 194.26M | 1.08% | 128,039 | 2.00M |
| 320 | ACOG | Alpha Cognition Inc. | 192.95M | 5.48% | 180,206 | 15.26M |
| 321 | CHRS | Coherus Oncology, Inc. | 190.04M | 0.82% | 1,886,519 | 50.94M |
| 322 | NBP | NovaBridge Biosciences | 189.08M | 3.82% | 180,373 | - |
| 323 | VYGR | Voyager Therapeutics, Inc. | 187.32M | -0.33% | 681,099 | 34.46M |
| 324 | ABOS | Acumen Pharmaceuticals, Inc. | 185.86M | -1.53% | 490,012 | - |
| 325 | ANTX | AN2 Therapeutics, Inc. | 184.91M | -8.24% | 204,492 | - |
| 326 | DTIL | Precision BioSciences, Inc. | 184.10M | 0.60% | 373,858 | 45.06M |
| 327 | KRRO | Korro Bio, Inc. | 173.76M | -14.68% | 400,438 | 2.38M |
| 328 | IPHA | Innate Pharma S.A. | 173.61M | -4.98% | 193,769 | 11.21M |
| 329 | MDWD | MediWound Ltd. | 172.74M | 1.21% | 44,315 | 11.86M |
| 330 | MNOV | MediciNova, Inc. | 169.81M | 36.90% | 7,413,206 | 920.48K |
| 331 | CNTN | Canton Strategic Holdings, Inc. | 167.33M | 2.94% | 697,457 | 1.50M |
| 332 | OTLK | Outlook Therapeutics, Inc. | 165.79M | 0.61% | 2,809,939 | -1.16M |
| 333 | NERV | Minerva Neurosciences, Inc. | 165.21M | -0.72% | 228,886 | - |
| 334 | RNA | Atrium Therapeutics, Inc. | 163.53M | 0.63% | 569,616 | 35.84M |
| 335 | HUMA | Humacyte, Inc. | 159.76M | 0.89% | 2,900,220 | 2.12M |
| 336 | SPRB | Spruce Biosciences, Inc. | 154.79M | -0.55% | 135,245 | 697.00K |
| 337 | MENS | Jyong Biotech Ltd. | 154.41M | 0.97% | 48,024 | - |
| 338 | ARMP | Armata Pharmaceuticals, Inc. | 152.45M | 0.74% | 253,540 | 5.54M |
| 339 | MOLN | Molecular Partners AG | 151.02M | - | 123 | 856.30K |
| 340 | TNYA | Tenaya Therapeutics, Inc. | 150.73M | 2.20% | 1,933,187 | 1.34M |
| 341 | CNXU | Conexeu Sciences Inc. | 149.50M | 14.72% | 242,382 | - |
| 342 | KZIA | Kazia Therapeutics Limited | 148.82M | 6.47% | 446,968 | 1.27M |
| 343 | NRXP | NRx Pharmaceuticals, Inc. | 146.66M | 1.19% | 788,018 | 3.39M |
| 344 | CDXS | Codexis, Inc. | 144.55M | -1.49% | 1,181,437 | 77.68M |
| 345 | IMUX | Immunic, Inc. | 141.22M | 2.27% | 578,354 | - |
| 346 | NMRA | Neumora Therapeutics, Inc. | 140.92M | -3.00% | 3,424,720 | - |
| 347 | CRBU | Caribou Biosciences, Inc. | 140.44M | 4.80% | 1,257,062 | 10.04M |
| 348 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 140.42M | - | 992,848 | - |
| 349 | HURA | TuHURA Biosciences, Inc. | 133.19M | 2.96% | 195,807 | - |
| 350 | UNCY | Unicycive Therapeutics, Inc. | 132.87M | -0.21% | 648,264 | - |
| 351 | LENZ | LENZ Therapeutics, Inc. | 129.77M | -0.24% | 889,126 | 21.48M |
| 352 | BMEA | Biomea Fusion, Inc. | 129.75M | 2.87% | 1,374,295 | - |
| 353 | MIST | Milestone Pharmaceuticals Inc. | 129.58M | 3.42% | 980,540 | 2.34M |
| 354 | ENGN | enGene Therapeutics Inc. | 128.00M | - | 637,548 | - |
| 355 | TLSA | Tiziana Life Sciences Ltd | 125.43M | 25.96% | 1,752,991 | - |
| 356 | INO | Inovio Pharmaceuticals, Inc. | 125.11M | 5.22% | 2,724,202 | 65.34K |
| 357 | CBUS | Cibus, Inc. | 124.58M | 7.95% | 121,971 | 4.35M |
| 358 | NAUT | Nautilus Biotechnology, Inc. | 123.65M | -0.04% | 679,246 | 190.00K |
| 359 | AARD | Aardvark Therapeutics, Inc. | 121.02M | 7.38% | 258,074 | - |
| 360 | PMN | ProMIS Neurosciences, Inc. | 120.71M | 4.50% | 22,780 | - |
| 361 | OKUR | OnKure Therapeutics, Inc. | 119.87M | 2.78% | 180,986 | - |
| 362 | EQ | Equillium, Inc. | 119.84M | 1.89% | 707,990 | 4.39M |
| 363 | RANI | Rani Therapeutics Holdings, Inc. | 118.71M | 12.65% | 665,044 | 4.88M |
| 364 | GNLX | Genelux Corporation | 113.37M | 8.12% | 295,259 | 8.00K |
| 365 | COYA | Coya Therapeutics, Inc. | 111.66M | 6.73% | 221,477 | 8.02M |
| 366 | BDTX | Black Diamond Therapeutics, Inc. | 110.89M | -0.52% | 665,316 | 70.00M |
| 367 | PMVP | PMV Pharmaceuticals, Inc. | 110.25M | 2.10% | 430,795 | - |
| 368 | VANI | Vivani Medical, Inc. | 109.15M | -0.82% | 219,841 | - |
| 369 | PLYX | Polaryx Therapeutics, Inc. | 106.67M | 5.42% | 27,550 | - |
| 370 | TENX | Tenax Therapeutics, Inc. | 106.54M | 2.20% | 3,565,114 | - |
| 371 | SEER | Seer, Inc. | 106.31M | 1.05% | 212,271 | 14.22M |
| 372 | PYPD | PolyPid Ltd. | 102.17M | -3.45% | 104,946 | - |
| 373 | CLLS | Cellectis S.A. | 101.99M | 6.18% | 347,333 | 63.82M |
| 374 | CRDF | Cardiff Oncology, Inc. | 101.13M | -3.70% | 1,134,788 | 508.00K |
| 375 | CGTX | Cognition Therapeutics, Inc. | 100.80M | 3.92% | 615,872 | - |
| 376 | ONCY | Oncolytics Biotech Inc. | 98.18M | 0.16% | 595,343 | - |
| 377 | ATRA | Atara Biotherapeutics, Inc. | 97.47M | -3.96% | 26,420 | 6.19M |
| 378 | ACET | Adicet Bio, Inc. | 96.99M | -0.44% | 130,650 | - |
| 379 | ANIX | Anixa Biosciences, Inc. | 95.95M | 6.15% | 345,553 | - |
| 380 | NRXS | NeurAxis, Inc. | 95.82M | 9.94% | 516,816 | 5.32M |
| 381 | GUTS | Fractyl Health, Inc. | 94.04M | 5.03% | 752,920 | 3.00K |
| 382 | NTRB | Nutriband Inc. | 92.99M | 8.66% | 102,846 | 1.62M |
| 383 | RLYB | Rallybio Corporation | 90.97M | 0.23% | 2,923 | 646.00K |
| 384 | ICCC | ImmuCell Corporation | 90.64M | 3.85% | 32,935 | 30.68M |
| 385 | PTHS | Pelthos Therapeutics Inc. | 85.68M | 15.24% | 30,544 | 43.30M |
| 386 | MAIA | MAIA Biotechnology, Inc. | 85.16M | - | 647,296 | - |
| 387 | NTHI | NeOnc Technologies Holdings, Inc. | 84.76M | 14.05% | 263,536 | 39.99K |
| 388 | OSTX | OS Therapies Incorporated | 84.41M | 4.57% | 2,229,793 | - |
| 389 | ALDX | Aldeyra Therapeutics, Inc. | 84.16M | 1.82% | 394,915 | - |
| 390 | FBIO | Fortress Biotech, Inc. | 83.71M | 2.03% | 167,432 | 68.47M |
| 391 | CNTB | Connect Biopharma Holdings Limited | 81.24M | 4.03% | 1,810,665 | 2.95M |
| 392 | IBIO | iBio, Inc. | 80.38M | 5.93% | 2,090,481 | 100.00K |
| 393 | VRCA | Verrica Pharmaceuticals Inc. | 79.88M | 2.65% | 41,282 | 30.32M |
| 394 | RNXT | RenovoRx, Inc. | 78.07M | 11.61% | 636,052 | 1.98M |
| 395 | BSEM | BioStem Technologies, Inc. | 77.82M | 6.86% | 119,629 | 34.59M |
| 396 | GANX | Gain Therapeutics, Inc. | 77.69M | 3.49% | 341,535 | - |
| 397 | TELO | Telomir Pharmaceuticals, Inc. | 77.03M | -0.88% | 153,956 | - |
| 398 | KLRS | Kalaris Therapeutics, Inc. | 75.22M | -0.63% | 43,336 | - |
| 399 | CING | Cingulate Inc. | 74.89M | 1.18% | 124,392 | - |
| 400 | GOSS | Gossamer Bio, Inc. | 72.96M | 8.94% | 267,636 | 53.29M |
| 401 | ACRV | Acrivon Therapeutics, Inc. | 72.85M | - | 463,727 | - |
| 402 | ELOX | Eloxx Pharmaceuticals, Inc. | 70.84M | 1.28% | 12,410 | - |
| 403 | PLRX | Pliant Therapeutics, Inc. | 69.97M | 5.61% | 308,084 | - |
| 404 | CSBR | Champions Oncology, Inc. | 69.87M | 1.41% | 28,880 | 60.66M |
| 405 | OKYO | OKYO Pharma Limited | 69.27M | -0.75% | 55,696 | - |
| 406 | RNTX | Rein Therapeutics Inc. | 68.08M | 12.41% | 262,679 | - |
| 407 | ALPS | Alps Group Inc | 66.54M | -0.03% | 17,519 | 3.74M |
| 408 | ATHE | Alterity Therapeutics Limited | 65.92M | -2.60% | 10,667 | 2.50M |
| 409 | XBIT | XBiotech Inc. | 65.85M | 0.47% | 32,112 | - |
| 410 | LONA | LeonaBio, Inc. | 65.43M | 2.28% | 5,246 | - |
| 411 | SPRO | Spero Therapeutics, Inc. | 65.22M | 0.90% | 181,774 | 47.00M |
| 412 | BOLD | Boundless Bio, Inc. | 63.69M | -1.06% | 92,210 | - |
| 413 | IBO | Impact BioMedical Inc. | 61.61M | 14.74% | 255,503 | 35.00K |
| 414 | HYFT | MindWalk Holdings Corp. | 61.55M | 15.93% | 390,333 | 11.57M |
| 415 | INMB | INmune Bio Inc. | 60.50M | 6.34% | 421,665 | 50.00K |
| 416 | HRTX | Heron Therapeutics, Inc. | 59.94M | -0.66% | 916,758 | 151.18M |
| 417 | INKT | MiNK Therapeutics, Inc. | 59.76M | 1.04% | 3,984 | - |
| 418 | XLO | Xilio Therapeutics, Inc. | 59.22M | 0.22% | 14,427 | 64.09M |
| 419 | DWTX | Dogwood Therapeutics, Inc. | 58.47M | 1.18% | 47,970 | - |
| 420 | EXOZ | eXoZymes, Inc. | 57.45M | 0.49% | 8,923 | -700.00 |
| 421 | IMA | ImageneBio, Inc. | 56.98M | 3.45% | 22,817 | 800.00K |
| 422 | SER | Serina Therapeutics, Inc. | 56.39M | 2.78% | 30,040 | 130.00K |
| 423 | EDSA | Edesa Biotech, Inc. | 55.94M | 6.98% | 24,726 | - |
| 424 | HYPD | Hyperion DeFi, Inc. | 53.92M | 6.12% | 337,459 | 1.40M |
| 425 | CLNN | Clene Inc. | 53.32M | 7.51% | 138,750 | 197.00K |
| 426 | TVGN | Tevogen Inc. | 49.81M | -1.92% | 2,289 | - |
| 427 | APLM | Apollomics, Inc. | 49.47M | 1.88% | 2,981 | 8.84M |
| 428 | ELTX | Elicio Therapeutics, Inc. | 49.02M | 5.37% | 340,174 | - |
| 429 | TIL | Instil Bio, Inc. | 48.90M | -0.28% | 11,682 | - |
| 430 | IMMP | Immutep Limited | 47.16M | -3.09% | 245,306 | 13.79M |
| 431 | PDSB | PDS Biotechnology Corporation | 47.14M | -14.98% | 35,878,142 | - |
| 432 | ANVS | Annovis Bio, Inc. | 46.87M | 5.77% | 1,522,833 | - |
| 433 | HOWL | Werewolf Therapeutics, Inc. | 46.80M | 4.79% | 583,750 | 21.00M |
| 434 | MREO | Mereo BioPharma Group plc | 46.33M | 9.06% | 1,744,778 | 500.00K |
| 435 | GRCE | Grace Therapeutics, Inc. | 44.81M | -0.47% | 74,482 | - |
| 436 | MGX | Metagenomi Therapeutics, Inc. | 42.69M | -1.74% | 100,739 | 13.56M |
| 437 | MCRB | Seres Therapeutics, Inc. | 40.76M | -2.61% | 44,422 | 1.88M |
| 438 | VERU | Veru Inc. | 40.75M | 3.02% | 93,898 | 16.89M |
| 439 | KPTI | Karyopharm Therapeutics Inc. | 40.60M | 5.29% | 1,089,111 | 146.62M |
| 440 | CRVO | CervoMed Inc. | 38.55M | 4.51% | 119,346 | 331.30K |
| 441 | ATNM | Actinium Pharmaceuticals, Inc. | 37.42M | -4.03% | 57,025 | 35.09M |
| 442 | ATYR | aTyr Pharma, Inc. | 36.93M | -1.98% | 1,004,490 | 190.00K |
| 443 | BCTX | BriaCell Therapeutics Corp. | 36.81M | 18.54% | 506,142 | - |
| 444 | CELU | Celularity Inc. | 36.76M | -1.55% | 77,746 | 26.55M |
| 445 | LITS | Lite Strategy, Inc. | 35.39M | 1.96% | 904,978 | - |
| 446 | CNTX | Context Therapeutics Inc. | 35.23M | 1.16% | 1,506,278 | - |
| 447 | FLNA | Filana Therapeutics, Inc. | 34.78M | 5.23% | 274,543 | - |
| 448 | ALGS | Aligos Therapeutics, Inc. | 32.28M | 2.38% | 21,703 | 31.52M |
| 449 | NNVC | NanoViricides, Inc. | 31.89M | 16.67% | 1,460,326 | - |
| 450 | QNTM | Quantum BioPharma Ltd. | 30.09M | 1.92% | 191,700 | - |
| 451 | ABVC | ABVC BioPharma, Inc. | 29.81M | 6.48% | 245,241 | 797.92K |
| 452 | KYNB | Kyntra Bio, Inc. | 29.80M | -3.29% | 38,618 | 4.62M |
| 453 | BYSI | BeyondSpring Inc. | 29.15M | - | 37,155 | 1.88M |
| 454 | RNAZ | TransCode Therapeutics, Inc. | 29.12M | 2.38% | 58,149 | - |
| 455 | IGC | IGC Pharma, Inc. | 27.54M | -2.06% | 716,115 | 1.11M |
| 456 | QNCX | Quince Therapeutics, Inc. | 27.47M | -0.59% | 11,835 | - |
| 457 | EVAX | Evaxion A/S | 26.86M | 6.27% | 53,339 | 7.49M |
| 458 | CVM | CEL-SCI Corporation | 26.21M | 0.68% | 43,372 | - |
| 459 | NXTC | NextCure, Inc. | 25.95M | -5.97% | 106,823 | - |
| 460 | PBM | Psyence Biomedical Ltd. | 24.11M | 8.59% | 134,571 | - |
| 461 | ATOS | Atossa Therapeutics, Inc. | 23.95M | -0.83% | 33,287 | - |
| 462 | ACTU | Actuate Therapeutics, Inc. | 23.90M | -0.22% | 174,545 | - |
| 463 | PLRZ | Polyrizon Ltd. | 23.21M | 3.57% | 159,375 | - |
| 464 | ESLA | Estrella Immunopharma, Inc. | 22.88M | -17.80% | 150,671 | - |
| 465 | CLRB | Cellectar Biosciences, Inc. | 22.69M | 2.13% | 71,669 | - |
| 466 | TCRX | TScan Therapeutics, Inc. | 22.60M | 0.76% | 1,096,257 | 7.11M |
| 467 | COCP | Cocrystal Pharma, Inc. | 21.96M | 0.44% | 13,821 | 330.00K |
| 468 | LTRN | Lantern Pharma Inc. | 21.86M | -11.40% | 278,684 | - |
| 469 | TVRD | Tvardi Therapeutics, Inc. | 21.61M | -6.36% | 192,940 | - |
| 470 | RADX | Radiopharm Theranostics Limited | 21.59M | 3.59% | 66,435 | 9.34M |
| 471 | GRDX | GridAI Technologies Corp. | 21.38M | 2.99% | 80,519 | - |
| 472 | JSPR | Jasper Therapeutics, Inc. | 21.10M | 9.16% | 303,548 | - |
| 473 | CMMB | Chemomab Therapeutics Ltd. | 20.29M | 5.66% | 130,593 | - |
| 474 | NEUP | Neuphoria Therapeutics Inc. | 20.08M | -0.67% | 4,871 | -13.27K |
| 475 | NCEL | NewcelX Ltd. | 19.52M | -0.29% | 12,191 | - |
| 476 | MRKR | Marker Therapeutics, Inc. | 19.51M | 2.63% | 60,596 | 3.55M |
| 477 | AKTX | Akari Therapeutics, Plc | 19.23M | -2.42% | 126,466 | - |
| 478 | ALLR | Allarity Therapeutics, Inc. | 18.46M | 0.43% | 160,612 | 345.00K |
| 479 | LPCN | Lipocine Inc. | 18.30M | 2.78% | 43,866 | 1.57M |
| 480 | PTN | Palatin Technologies, Inc. | 18.10M | 9.09% | 34,201 | 12.88M |
| 481 | KPRX | Kiora Pharmaceuticals, Inc. | 16.99M | 2.69% | 19,737 | 20.00K |
| 482 | KTTA | Pasithea Therapeutics Corp. | 16.93M | 3.41% | 238,104 | - |
| 483 | BCDA | BioCardia, Inc. | 16.80M | -11.20% | 417,287 | 3.00K |
| 484 | PASG | Passage Bio, Inc. | 16.22M | 2.06% | 3,317 | - |
| 485 | CTXR | Citius Pharmaceuticals, Inc. | 16.14M | 4.98% | 245,902 | 7.11M |
| 486 | LSTA | Lisata Therapeutics, Inc. | 15.68M | 18.37% | 3,043,748 | 100.00K |
| 487 | NIKI | Niki BioSolutions, Inc. | 15.46M | 10.27% | 137,426 | - |
| 488 | DYAI | Dyadic International, Inc. | 15.44M | 5.24% | 173,361 | 3.80M |
| 489 | ICU | SeaStar Medical Holding Corporation | 15.41M | 13.55% | 78,104 | 1.71M |
| 490 | CNSY | Cerenome, Inc. | 15.41M | -0.49% | 76,857 | 4.20M |
| 491 | MBRX | Moleculin Biotech, Inc. | 15.19M | 5.41% | 304,825 | - |
| 492 | TPST | Tempest Therapeutics, Inc. | 14.80M | -26.03% | 7,869,132 | - |
| 493 | QNRX | Quoin Pharmaceuticals, Ltd. | 14.08M | 1.59% | 28,110 | - |
| 494 | HIND | Vyome Holdings, Inc. | 13.76M | 0.51% | 4,871 | 129.73K |
| 495 | ADIL | Adial Pharmaceuticals, Inc. | 13.68M | -0.57% | 21,541 | - |
| 496 | GTBP | GT Biopharma, Inc. | 13.51M | -4.10% | 110,544 | - |
| 497 | CALC | CalciMedica, Inc. | 13.45M | -0.51% | 98,729 | - |
| 498 | BIVI | BioVie Inc. | 13.43M | 3.49% | 478,831 | - |
| 499 | PLUR | Pluri Inc. | 13.33M | -5.26% | 41,594 | 1.02M |
| 500 | MLEC | Moolec Science SA | 12.96M | 3.32% | 6,127 | 7.83M |